The US has bought up most of the world’s supply of remdesivir. This type of treatment nationalism is nothing new, though.
Articles on Remdesivir
Displaying 21 - 32 of 32 articles
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.
As the United States risks prompting a bidding war for coronavirus drugs, can the world show solidarity over equitable access to medicines? And is remdesivir any use against COVID-19 anyway?
Treatment nationalism is a threat to us all.
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
A mutating coronavirus has implications for vaccines, treatments, tests and your future plans.
A simple head-to-head trial would resolve this conflict once and for all.
Gilead’s drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
Preliminary results from a US trial show remdesivir may help in treating COVID-19. But the findings haven’t been peer-reviewed, and the results from other clinical trials have shown little effect.
Vaccines for other diseases are being examined for their protective effects against coronavirus.
Coronavirus drug trials are underway – a virologist explains what the treatment options may be.
Among the more than 20,000 drugs approved by the FDA, there may be some that can treat COVID-19. A team at the University of California, San Francisco, is identifying possible candidates.
Top contributors
-
Professor of Philosophy, Binghamton University, State University of New York
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Professor of Medicine, University of Virginia
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor in Viral Immunology, University of Birmingham
-
Professor of Chemistry and Biological Chemistry, University of Michigan
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Pharmacist and PhD Candidate, University of Sydney
-
Professor, Chemistry, University of York
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Global Health Law Fellow, University Medical Centre Groningen, University of Groningen
-
Lecturer of Law, Global Health, Keele University
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Assistant Professor of Medicine, University of Pittsburgh